CCL2 and breast carcinoma: An elevated expression linked to enhanced tumor growth is recapitulated in experimental models of breast cancer, including orthotopic syngeneic grafting models, where TNC or CCL2 expression contributes to disease progression [22,23,24,25,26,27].